Glaukos (GKOS) Revenue & Revenue Breakdown
Glaukos Revenue Highlights
Latest Revenue (Y)
$314.71M
Latest Revenue (Q)
$96.67M
Main Segment (Y)
Glaucoma
Main Geography (Y)
United States
Glaukos Revenue by Period
Glaukos Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $314.71M | 11.26% |
| 2022-12-31 | $282.86M | -3.79% |
| 2021-12-31 | $294.01M | 30.70% |
| 2020-12-31 | $224.96M | -5.07% |
| 2019-12-31 | $236.98M | 30.73% |
| 2018-12-31 | $181.28M | 13.83% |
| 2017-12-31 | $159.25M | 39.21% |
| 2016-12-31 | $114.40M | 59.55% |
| 2015-12-31 | $71.70M | 57.28% |
| 2014-12-31 | $45.59M | 117.64% |
| 2013-12-31 | $20.95M | - |
Glaukos generated $314.71M in revenue during NA 2023, up 11.26% compared to the previous quarter, and up 173.61% compared to the same period a year ago.
Glaukos Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $96.67M | 1.02% |
| 2024-06-30 | $95.69M | 11.76% |
| 2024-03-31 | $85.62M | 3.95% |
| 2023-12-31 | $82.36M | 5.53% |
| 2023-09-30 | $78.05M | -2.92% |
| 2023-06-30 | $80.40M | 8.80% |
| 2023-03-31 | $73.90M | 3.75% |
| 2022-12-31 | $71.23M | -0.06% |
| 2022-09-30 | $71.27M | -1.95% |
| 2022-06-30 | $72.69M | 7.39% |
| 2022-03-31 | $67.68M | -7.59% |
| 2021-12-31 | $73.24M | -1.97% |
| 2021-09-30 | $74.71M | -4.33% |
| 2021-06-30 | $78.09M | 14.90% |
| 2021-03-31 | $67.97M | -7.19% |
| 2020-12-31 | $73.23M | 12.96% |
| 2020-09-30 | $64.83M | 105.43% |
| 2020-06-30 | $31.56M | -42.97% |
| 2020-03-31 | $55.34M | -15.97% |
| 2019-12-31 | $65.85M | 12.55% |
| 2019-09-30 | $58.51M | -0.16% |
| 2019-06-30 | $58.60M | 8.47% |
| 2019-03-31 | $54.03M | -0.09% |
| 2018-12-31 | $54.08M | 23.16% |
| 2018-09-30 | $43.91M | 1.73% |
| 2018-06-30 | $43.16M | 7.54% |
| 2018-03-31 | $40.13M | -3.64% |
| 2017-12-31 | $41.65M | 3.06% |
| 2017-09-30 | $40.41M | -2.11% |
| 2017-06-30 | $41.28M | 14.98% |
| 2017-03-31 | $35.91M | 8.24% |
| 2016-12-31 | $33.17M | 12.15% |
| 2016-09-30 | $29.58M | 3.58% |
| 2016-06-30 | $28.56M | 23.66% |
| 2016-03-31 | $23.09M | 13.89% |
| 2015-12-31 | $20.28M | 6.69% |
| 2015-09-30 | $19.00M | 7.04% |
| 2015-06-30 | $17.75M | 21.06% |
| 2015-03-31 | $14.67M | 3.92% |
| 2014-12-31 | $14.11M | 16.39% |
| 2014-09-30 | $12.13M | 9.25% |
| 2014-06-30 | $11.10M | 34.55% |
| 2014-03-31 | $8.25M | - |
Glaukos generated $96.67M in revenue during Q3 2024, up 1.02% compared to the previous quarter, and up 120.24% compared to the same period a year ago.
Glaukos Revenue Breakdown
Glaukos Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 |
|---|---|
| Glaucoma | $230.97M |
| Corneal Health | $6.02M |
Glaukos's latest annual revenue breakdown by segment (product or service), as of Dec 19: Glaucoma (97.46%), and Corneal Health (2.54%).
Quarterly Revenue by Product
| Product/Service | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|
| Corneal Health | $14.88M | $12.90M | $6.61M | $11.20M |
| Glaucoma | $58.36M | $51.93M | $24.95M | $44.13M |
Glaukos's latest quarterly revenue breakdown by segment (product or service), as of Dec 20: Glaucoma (79.68%), and Corneal Health (20.32%).
Glaukos Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| International | $95.31M | - | - | - | - |
| United States | $219.40M | $144.66M | $170.80M | - | - |
| Non Us | - | - | - | $45.64M | $44.53M |
| U | - | - | - | $133.72M | $192.46M |
Glaukos's latest annual revenue breakdown by geography, as of Dec 23: United States (69.71%), and International (30.29%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $70.02M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-US | $26.65M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| United States | - | $66.82M | $57.69M | $144.69M | $39.60M | $35.11M | $35.35M | $37.21M | $38.20M | $33.90M | $41.21M | - | - | - | - | - | - | - | - | - |
| International | - | $28.87M | $27.93M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non Us | - | - | - | - | - | - | - | - | - | - | - | $15.10M | $16.41M | $13.81M | $16.30M | $14.23M | $7.39M | $13.95M | $13.29M | $10.92M |
| U | - | - | - | - | - | - | - | - | - | - | - | $43.38M | $46.31M | $39.89M | $56.93M | $50.60M | $24.17M | $41.38M | $52.56M | $47.59M |
Glaukos's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (72.43%), and Non-US (27.57%).
Glaukos Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BRKR | Bruker | $2.96B | $800.70M |
| ITGR | Integer | $1.60B | $746.27M |
| CNMD | CONMED | $1.24B | $316.70M |
| LIVN | LivaNova | $1.15B | $318.11M |
| NVRO | Nevro | $425.17M | $104.16M |
| GKOS | Glaukos | $314.71M | $96.67M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $126.08M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $20.16M |
| IRMD | IRadimed | $65.56M | $18.33M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |